Skip to content

Jiangsu Recbio Technology Co Ltd Sustainability Reports

The company is an innovative vaccine enterprise primarily engaged in the research, development, and commercialization of high-value recombinant protein, HPV, and shingles vaccine candidates.

Sector: Manufacturing

Country: China

Exchange: Hong Kong Stock Exchange

LEI: 254900UBG3389KI4UR87

FIGI: BBG0167SQCH3

9 reports from 2021 to 2025